Drug:
Reaction: WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940405 |
EU |
||
Foreign body in throat, Wrong technique in product usage process, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 2 | 26940602 |
US |
1 | |
Heart rate increased, Arthralgia, Bone pain, Injection site haemorrhage, Injection site bruising, Wrong technique in product usage process, Liquid product physical issue, Device defective, |
||||
ABALOPARATIDE, |
||||
| 3 | 26940671 |
US |
||
Wrong technique in product usage process, |
||||
SELEXIPAG, |
||||
| 4 | 26940685 |
US |
||
Keratomileusis, Visual impairment, Product dose omission issue, Corrective lens user, Wrong technique in product usage process, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 5 | 26940802 |
US |
78 | 2 |
Epistaxis, Finger deformity, Bone deformity, Wrong technique in product usage process, Product use in unapproved indication, |
||||
ABALOPARATIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, FLUTICASONE PROPIONATE, LISINOPRIL, METHIMAZOLE, OXYBUTYNIN CHLORIDE, PANTOPRAZOLE, |
||||
| 6 | 26940934 |
US |
2 | |
Wrong technique in product usage process, Injection site discomfort, |
||||
ABALOPARATIDE, |
||||
| 7 | 26940953 |
CN |
1 | |
Pneumoperitoneum, Wrong technique in product usage process, |
||||
| 8 | 26941413 |
US |
69 | |
Wrong technique in product usage process, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 9 | 26941485 |
US |
77 | 2 |
Angina bullosa haemorrhagica, Device delivery system issue, Wrong technique in product usage process, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, LOSARTAN, |
||||
| 10 | 26941521 |
US |
2 | |
Hip arthroplasty, Knee operation, Arthralgia, Skin plaque, Intentional product misuse, Wrong technique in product usage process, |
||||
APREMILAST, APREMILAST, APREMILAST, |
||||
| 11 | 26941809 |
US |
77 | 2 |
Paraesthesia, Injection site bruising, Headache, Nausea, Diarrhoea, Bone pain, Product dose omission in error, Wrong technique in product usage process, Product use in unapproved indication, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DULOXETINE HYDROCHLORIDE, MODAFINIL, DILTIAZEM HYDROCHLORIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE, ATORVASTATIN CALCIUM, CLOPIDOGREL, FLUTICASONE PROPIONATE AND SALMETEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, PRASTERONE, CEVIMELINE HYDROCHLORIDE, PREDNISONE, DEXLANSOPRAZOLE, FAMOTIDINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PREGABALIN, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CLONAZEPAM, CELECOXIB, SILDENAFIL CITRATE, LEVOCETIRIZINE DIHYDROCHLORIDE, RITUXIMAB, DESMOPRESSIN ACETATE, LEVOTHYROXINE SODIUM, HYDROXYCHLOROQUINE SULFATE, DIPYRIDAMOLE, |
||||
| 12 | 26941835 |
US |
2 | |
Dyspepsia, Crepitations, Palpitations, Injection site pain, Wrong technique in product usage process, Product dose omission issue, Product communication issue, |
||||
ABALOPARATIDE, SIMVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 13 | 26942337 |
US |
44 | 1 |
Injection site pain, Wrong technique in product usage process, Incorrect dose administered, Accidental exposure to product, |
||||
FREMANEZUMAB-VFRM, |
||||
| 14 | 26942517 |
US |
70 | 2 |
Injection site pain, Wrong technique in product usage process, |
||||
EVOLOCUMAB, |
||||
| 15 | 26942524 |
US |
||
Intercepted product preparation error, Wrong technique in product usage process, Product packaging quantity issue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 16 | 26942591 |
US |
||
Wrong technique in product usage process, Product packaging quantity issue, Product quality issue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 17 | 26942666 |
US |
71 | 2 |
Hip arthroplasty, Dermatitis contact, Musculoskeletal chest pain, Eructation, Chest discomfort, Device use error, Wrong technique in product usage process, Back pain, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 18 | 26942673 |
US |
67 | |
Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, |
||||
| 19 | 26942678 |
US |
53 | |
Wrong technique in product usage process, Off label use, |
||||
ALBUTEROL SULFATE, |
||||
| 20 | 26942698 |
US |
2 | |
Nausea, Wrong technique in product usage process, Headache, Drug intolerance, |
||||
ORAL SEMAGLUTIDE, |
||||
| 21 | 26942739 |
US |
4 | 1 |
Drug ineffective, Wrong technique in product usage process, |
||||
IVERMECTIN, |
||||
| 22 | 26942810 |
US |
66 | 2 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 23 | 26943166 |
US |
||
Wrong technique in product usage process, Device delivery system issue, Device leakage, |
||||
OCTREOTIDE ACETATE, |
||||
| 24 | 26943189 |
US |
74 | |
Accidental exposure to product, Wrong technique in product usage process, Device occlusion, Product physical issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, |
||||
| 25 | 26943551 |
US |
49 | 2 |
Systemic lupus erythematosus, Injection site bruising, Wrong technique in product usage process, General physical health deterioration, Sensitive skin, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 26 | 26943625 |
US |
80 | 1 |
Product storage issue, Wrong technique in product usage process, |
||||
INSULIN GLARGINE, |
||||
| 27 | 26943685 |
US |
2 | |
Blood pressure decreased, Wrong technique in product usage process, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, |
||||
| 28 | 26943860 |
US |
65 | 2 |
Nausea, Wrong technique in product usage process, Headache, Off label use, |
||||
| 29 | 26943985 |
US |
89 | 2 |
Wrong technique in product usage process, Device difficult to use, No adverse event, |
||||
TOCILIZUMAB, |
||||
| 30 | 26944158 |
US |
||
Dysphagia, Wrong technique in product usage process, |
||||
| 31 | 26944313 |
2 | ||
Wrong technique in product usage process, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 32 | 26944503 |
US |
63 | 1 |
Product communication issue, Wrong technique in product usage process, Device breakage, Irritability, Accidental exposure to product, |
||||
EVOLOCUMAB, |
||||
| 33 | 26944522 |
US |
2 | |
Visual impairment, Product dose omission in error, Wrong technique in product usage process, Product closure removal difficult, |
||||
LATANOPROST, TIMOLOL, |
||||
| 34 | 26945109 |
US |
83 | 2 |
Product container seal issue, Incorrect dose administered by device, Product use issue, Wrong technique in product usage process, Product communication issue, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 35 | 26945144 |
US |
75 | 2 |
Device loosening, Device malfunction, Product dose omission issue, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 36 | 26945167 |
US |
2 | |
Headache, Dizziness, Nausea, Intentional product use issue, Wrong technique in product usage process, Product communication issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 37 | 26945256 |
US |
2 | |
Injection site pain, Wrong technique in product usage process, Drug delivery system malfunction, Product dose omission issue, Liquid product physical issue, Device leakage, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN, LISINOPRIL, FAMOTIDINE, |
||||
| 38 | 26945465 |
US |
10 | |
Nausea, Vomiting, Off label use, Wrong technique in product usage process, |
||||
RUXOLITINIB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 39 | 26945530 |
US |
88 | 1 |
Myocardial infarction, Wrong technique in product usage process, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 40 | 26945540 |
US |
2 | |
Injection site discolouration, Injection site swelling, Injection site pruritus, Fatigue, Product administered at inappropriate site, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
| 41 | 26945576 |
US |
2 | |
Incorrect dose administered, Wrong technique in product usage process, No adverse event, |
||||
OMALIZUMAB, |
||||
| 42 | 26945589 |
US |
2 | |
Wrong technique in product usage process, Drug dose omission by device, Product outer packaging issue, Device mechanical issue, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 43 | 26945682 |
US |
77 | 2 |
Abdominal rigidity, Memory impairment, Device connection issue, Wrong technique in product usage process, |
||||
ABALOPARATIDE, INSULIN DEGLUDEC, ORAL SEMAGLUTIDE, ROSUVASTATIN, PANTOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 44 | 26945697 |
US |
24 | 2 |
Wrong technique in product usage process, Injection site mass, |
||||
OMALIZUMAB, |
||||
| 45 | 26945724 |
US |
2 | |
Hair growth abnormal, Bone pain, Fatigue, Arthralgia, Headache, Product dose omission issue, Wrong technique in product usage process, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, BIOTIN, DEXLANSOPRAZOLE, ISOSORBIDE MONONITRATE, LOSARTAN, MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ERGOCALCIFEROL, |
||||
| 46 | 26945923 |
US |
2 | |
Nausea, Inability to afford medication, Device use issue, Product dose omission issue, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
| 47 | 26945975 |
SG |
63 | 2 |
Sepsis, Wrong technique in product usage process, |
||||
LANTHANUM CARBONATE, |
||||
| 48 | 26946043 |
US |
69 | 2 |
Dysphonia, Oropharyngeal pain, Injection site bruising, Product dose omission in error, Product use in unapproved indication, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ALPRAZOLAM, LORATADINE, LORATADINE ORAL, DEXLANSOPRAZOLE, FLUTICASONE PROPIONATE, FUROSEMIDE, IMIPRAMINE HYDROCHLORIDE, NADOLOL, PROGESTERONE, ERGOCALCIFEROL, |
||||
| 49 | 26946151 |
US |
80 | 2 |
Drug dose omission by device, Wrong technique in product usage process, Device mechanical issue, |
||||
ABALOPARATIDE, CELECOXIB, GABAPENTIN, |
||||
| 50 | 26946345 |
US |
2 | |
Injection site discomfort, Sensitive skin, Injection site pain, Wrong technique in product usage process, |
||||
ABALOPARATIDE, LEVOTHYROXINE SODIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MELOXICAM, HYDROCHLOROTHIAZIDE, SERTRALINE HYDROCHLORIDE, PENICILLIN V POTASSIUM, |
||||
| 51 | 26946385 |
US |
61 | 2 |
Injection site pain, Device defective, Device failure, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 52 | 26946683 |
US |
2 | |
Dysgeusia, Injection site pain, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
| 53 | 26946838 |
US |
53 | 2 |
Sleep disorder, Parosmia, Wrong technique in product usage process, Incorrect dose administered by device, |
||||
ABALOPARATIDE, |
||||
| 54 | 26946914 |
US |
80 | 2 |
Arthralgia, Dizziness, Pain, Drug dose omission by device, Device mechanical issue, Wrong technique in product usage process, Product communication issue, |
||||
ABALOPARATIDE, |
||||
| 55 | 26946954 |
US |
77 | 2 |
Illness, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LATANOPROST, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, |
||||
| 56 | 26946989 |
US |
82 | 2 |
Product dose omission issue, Product administered at inappropriate site, Wrong technique in product usage process, Device mechanical issue, Product dose omission in error, |
||||
ABALOPARATIDE, ROMOSOZUMAB-AQQG, |
||||
| 57 | 26947319 |
US |
69 | 2 |
Device defective, Wrong technique in product usage process, Product administration error, |
||||
ABALOPARATIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PANTOPRAZOLE, EZETIMIBE, IRBESARTAN, CALCIUM, ERGOCALCIFEROL, |
||||
| 58 | 26947494 |
US |
59 | 2 |
Injection site bruising, Drug delivery system issue, Device use issue, Device issue, Wrong technique in product usage process, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 59 | 26947679 |
US |
2 | |
Injection site mass, Palpitations, Injection site pruritus, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 60 | 26947806 |
US |
77 | |
Prostate cancer, Heart valve replacement, Wrong technique in product usage process, Glycosylated haemoglobin increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, ORAL SEMAGLUTIDE, |
||||
| 61 | 26947856 |
US |
75 | 2 |
Myalgia, Gastrointestinal sounds abnormal, Decreased appetite, Abdominal discomfort, Abdominal pain upper, Arthralgia, Headache, Pain, Asthenia, Unevaluable event, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, PSYLLIUM HUSK, |
||||
| 62 | 26947892 |
US |
70 | 2 |
Migraine, Wrong technique in product usage process, Product communication issue, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 63 | 26947910 |
US |
2 | |
Decreased appetite, Hot flush, Headache, Injection site bruising, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
| 64 | 26948212 |
US |
75 | 2 |
Injection site bruising, Product communication issue, Device difficult to use, Wrong technique in product usage process, Drug dose omission by device, Incorrect product administration duration, |
||||
EVOLOCUMAB, EVOLOCUMAB, TIRZEPATIDE, |
||||
| 65 | 26934167 |
59 | ||
Adverse drug reaction, Wrong technique in product usage process, Somnolence, Chest discomfort, Panic disorder, Dizziness, Palpitations, |
||||
METOPROLOL TARTRATE, ALPRAZOLAM, ERGOCALCIFEROL, ESTRADIOL/NORETHINDRONE ACETATE, |
||||
| 66 | 26934194 |
60 | ||
Fatigue, Palpitations, Chest discomfort, Heart rate irregular, Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 67 | 26934201 |
67 | ||
Musculoskeletal discomfort, Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, |
||||
| 68 | 26934210 |
|||
Dyspnoea, Heart rate increased, Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 69 | 26934214 |
56 | ||
Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, |
||||
| 70 | 26934216 |
72 | ||
Palpitations, Nausea, Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, LEVOTHYROXINE SODIUM, |
||||
| 71 | 26934221 |
78 | ||
Arthralgia, Fatigue, Insomnia, Asthenia, Headache, Drug ineffective, Palpitations, Wrong technique in product usage process, Dyspnoea, |
||||
METOPROLOL TARTRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, DEXAMETHASONE, EZETIMIBE, SIMVASTATIN, |
||||
| 72 | 26934227 |
58 | ||
Drug ineffective, Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, LORATADINE, LORATADINE TABLET, LANSOPRAZOLE, |
||||
| 73 | 26934251 |
US |
21 | 1 |
Wrong technique in product usage process, |
||||
ISAVUCONAZONIUM SULFATE, ISAVUCONAZONIUM SULFATE, |
||||
| 74 | 26934325 |
72 | ||
Palpitations, Wrong technique in product usage process, Nausea, |
||||
METOPROLOL TARTRATE, LEVOTHYROXINE SODIUM, |
||||
| 75 | 26934488 |
89 | ||
Wrong technique in product usage process, Drug ineffective, Product quality issue, |
||||
METOPROLOL TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 76 | 26934513 |
76 | ||
Hypoacusis, Somnolence, Psychiatric symptom, Wrong technique in product usage process, Intentional product misuse, Therapy non-responder, Product complaint, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LOSARTAN, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 77 | 26934545 |
US |
||
Accident, Off label use, Wrong technique in product usage process, Monocular vision, |
||||
CYCLOSPORINE, |
||||
| 78 | 26934613 |
US |
1 | |
Throat irritation, Drug ineffective, Underdose, Product use issue, Wrong technique in product usage process, |
||||
SALMETEROL XINAFOATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 79 | 26934745 |
US |
30 | 2 |
Rheumatoid arthritis, Injection site haemorrhage, Cough, Nasopharyngitis, Oropharyngeal pain, Illness, Chest pain, Injection site discolouration, Injection site swelling, Wrong technique in product usage process, Injection site pain, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 80 | 26934752 |
US |
80 | 2 |
Drug dose omission by device, Wrong technique in product usage process, Product storage error, Memory impairment, |
||||
ETANERCEPT, |
||||
| 81 | 26934956 |
US |
77 | 2 |
Atrial fibrillation, Wrong technique in product usage process, Nasopharyngitis, Musculoskeletal stiffness, Rhinorrhoea, Oropharyngeal discomfort, Drug hypersensitivity, Incorrect disposal of product, Product storage issue, Product communication issue, Adverse drug reaction, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 82 | 26934967 |
US |
2 | |
Product packaging difficult to open, Wrong technique in product usage process, Poor quality product administered, |
||||
ISOTRETINOIN, |
||||
| 83 | 26935439 |
US |
2 | |
Fatigue, Nausea, Pain in extremity, Injection site pain, Malaise, Wrong technique in product usage process, Dyspnoea, |
||||
ETANERCEPT, |
||||
| 84 | 26935514 |
US |
67 | |
Wrong technique in product usage process, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 85 | 26935770 |
US |
75 | 2 |
Disability, Accidental exposure to product, Exposure via skin contact, Product administration error, Product communication issue, Wrong technique in product usage process, Drug dose omission by device, |
||||
DENOSUMAB, |
||||
| 86 | 26935819 |
US |
2 | |
Product dose omission issue, Wrong technique in product usage process performed in error, Wrong technique in product usage process, Product use in unapproved indication, Product complaint, |
||||
ALBUTEROL SULFATE, |
||||
| 87 | 26935926 |
US |
1 | |
Injury associated with device, Product packaging difficult to open, Wrong technique in product usage process, |
||||
ORAL SEMAGLUTIDE, |
||||
| 88 | 26936256 |
US |
||
Product administration error, Wrong technique in product usage process, Wrong device used, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 89 | 26936397 |
US |
73 | 1 |
Dementia with Lewy bodies, Wrong technique in product usage process, |
||||
EVOLOCUMAB, |
||||
| 90 | 26936403 |
EU |
2 | |
Unevaluable event, Skin mass, Incorrect route of product administration, Wrong technique in product usage process, |
||||
FULVESTRANT, FULVESTRANT, RIBOCICLIB, DENOSUMAB, |
||||
| 91 | 26936581 |
CN |
2 | |
Pneumoperitoneum, Wrong technique in product usage process, |
||||
| 92 | 26936591 |
US |
||
Wrong technique in product usage process, Product adhesion issue, Product physical issue, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, ESTRADIOL, |
||||
| 93 | 26937210 |
US |
2 | |
Amnesia, Wrong technique in product usage process, Injection site discharge, |
||||
ADALIMUMAB, |
||||
| 94 | 26937462 |
US |
58 | |
Full blood count decreased, Anaemia, Decreased appetite, Insomnia, Wrong technique in product usage process, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
| 95 | 26937782 |
PH |
||
Pancreatic carcinoma, Prescribed underdose, Wrong technique in product usage process, Product prescribing issue, |
||||
TOLVAPTAN, |
||||
| 96 | 26938354 |
US |
65 | 2 |
Abdominal pain upper, Product prescribing error, Product use issue, Wrong technique in product usage process, |
||||
| 97 | 26938590 |
US |
2 | |
Tooth disorder, Blood pressure increased, Noninfective gingivitis, Wrong technique in product usage process, |
||||
BRENSOCATIB, AMLODIPINE, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, CALCIUM CARBONATE, ANTACID, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, RIMEGEPANT SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, ERGOCALCIFEROL, |
||||
| 98 | 26939022 |
US |
2 | |
Pyrexia, Blood pressure increased, Injection site reaction, Dizziness, Heart rate increased, Nausea, Headache, Vomiting, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 99 | 26939084 |
US |
59 | 2 |
Wrong technique in product usage process, Product knowledge deficit, |
||||
EVOLOCUMAB, |
||||
| 100 | 26939113 |
US |
2 | |
Vascular rupture, Hot flush, Fatigue, Back pain, Injection site bruising, Product dose omission in error, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30